301015.SZ SHZ
Qingdao Baheal Medical Inc.
1W: -2.8%
1M: +4.6%
3M: +26.6%
YTD: +7.5%
1Y: +2.8%
3Y: +2.9%
¥25.68 ($3.83)
+0.64 (+2.56%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$814M
+1.8% ▲
5Y CAGR: +77.7%
Capital Expenditures
$304M
-63.9% ▼
5Y CAGR: +152.6%
Free Cash Flow
$510M
-17.0% ▼
5Y CAGR: +64.0%
Dividends Paid
$450M
-2.2% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$88M
-48.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $273M | $422M | $507M | $656M | $767M |
| Depreciation & Amort. | $23M | $53M | $62M | $55M | $86M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$493M | -$345M | -$309M | -$113M | -$91M |
| Other Non-Cash Items | $80M | $45M | $58M | $216M | $52M |
| Operating Cash Flow | -$117M | $181M | $306M | $799M | $814M |
| — Investing Activities — | |||||
| Capital Expenditures | -$16M | -$27M | -$105M | -$129M | -$304M |
| Acquisitions (Net) | $350K | -$45M | -$33M | $17M | $1M |
| Investment Purchases | -$584M | -$56M | -$71M | -$94M | -$824M |
| Investment Sales | $553M | $52M | $52M | $41M | $393M |
| Other Investing | $4M | $54M | $39M | -$131M | $790K |
| Investing Cash Flow | -$43M | -$23M | -$117M | -$296M | -$732M |
| — Financing Activities — | |||||
| Net Debt Issuance | $238M | -$26M | -$34M | $207M | $1.1B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$149M | -$56M | -$350M | -$440M | -$450M |
| Other Financing | $217M | $120M | -$160M | -$100M | -$599M |
| Financing Cash Flow | $306M | $38M | -$544M | -$333M | $5M |
| Net Change in Cash | $145M | $195M | -$349M | $171M | $88M |
| Cash End of Period | $947M | $1.1B | $793M | $1.1B | $1.2B |
| Free Cash Flow | -$130M | $154M | $200M | $614M | $510M |